VERA

Shares of hair-loss treatment developer Veradermics more than doubled in early first-day trading on the New York Stock Exchange. The soaring IPO demonstrates continued investor interest in companies addressing pattern hair loss, despite a generally tough market for biotech public offerings.

AI-generated: summaries written by AI from the linked sources. How we use AI